CBIO
CRESCENT BIOPHARMA, INC.
NASDAQ · Healthcare · Biotechnology · US
$16.89
+0.72%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$16.60
From 52W high−37.40%
Volume3.12M
Market cap$627.36M
P/E (TTM)—
P/S (TTM)52.8x
Div yield—
Key dataSep 18, 2026
Open
$16.60
From 52W high
−37.40%
Volume
3.12M
Market cap
$627.36M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−2.8x
P/E (TTM)
—
RSI (14)
42.4
MomentumView details →
1D Return
+0.72%
YTD Return
+41.53%
Similar companies
Latest newsMore news →
Crescent Biopharma, Inc. reported its financial results for the second quarter of 2026, with zero revenue, a net loss of $24.8 million, and a diluted EPS of -0.74.53d agoCrescent Biopharma granted equity inducement awards to two new non-executive employees to secure their acceptance of employment.59d ago